• Je něco špatně v tomto záznamu ?

Achiral and chiral high-performance liquid chromatographic determination of flubendazole and its metabolites in biomatrices using UV photodiode-array and mass spectrometric detection

Nobilis M, Jira T, Lísa M, Holcapek M, Szotáková B, Lamka J, Skálová L.

Jazyk angličtina Země Nizozemsko

Typ dokumentu validační studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc10001275

Flubendazole, methyl ester of [5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamic acid, belongs to the group of benzimidazole anthelmintics, which are widely used in veterinary and human medicine. The phase I flubendazole biotransformation includes a hydrolysis of the carbamoyl methyl moiety accompanied by a decarboxylation (hydrolysed flubendazole) and a carbonyl reduction of flubendazole (reduced flubendazole). Flubendazole is a prochiral drug, hence a racemic mixture is formed during non-stereoselective reductions at the carbonyl group. Two bioanalytical HPLC methods were developed and validated for the determination of flubendazole and its metabolites in pig and pheasant hepatic microsomal and cytosolic fractions. Analytes were extracted from biomatrices into tert-butylmethyl ether. The first, achiral method employed a 250 mm x 4 mm column with octylsilyl silica gel (5 microm) and an isocratic mobile phase acetonitrile-0.025 M KH(2)PO(4) buffer pH 3 (28:72, v/v). Albendazole was used as an internal standard. The whole analysis lasted 27 min at a flow rate of 1 ml/min. The second, chiral HPLC method, was performed on a Chiralcel OD-R 250 mm x 4.6 mm column with a mobile phase acetonitrile-1 M NaClO(4) (4:6, v/v). This method enabled the separation of both reduced flubendazole enantiomers. The enantiomer excess was evaluated. The column effluent was monitored using a photodiode-array detector (scan or single wavelength at lambda=246 nm). Each of the analytes under study had characteristic UV spectrum, in addition, their chemical structures were confirmed by high-performance liquid chromatography-mass spectrometry (HPLC-MS) experiments. Stereospecificity in the enzymatic carbonyl reduction of flubendazole was observed. While synthetic racemic mixture of reduced flubendazole was separated to equimolar amounts of both enantiomers, practically only one enantiomer was detected in the extracts from all incubates.

000      
00000naa 2200000 a 4500
001      
bmc10001275
003      
CZ-PrNML
005      
20111210155203.0
008      
100121s2007 ne e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Nobilis, Milan $7 xx0079581
245    10
$a Achiral and chiral high-performance liquid chromatographic determination of flubendazole and its metabolites in biomatrices using UV photodiode-array and mass spectrometric detection / $c Nobilis M, Jira T, Lísa M, Holcapek M, Szotáková B, Lamka J, Skálová L.
314    __
$a Institute of Experimental Biopharmaceutics, Joint Research Center of PRO.MED.CS Praha a.s. and Academy of Sciences of the Czech Republic, Heyrovského, Hradec Králové, Czech Republic. nobilis@uebf.cas.cz <nobilis@uebf.cas.cz>
520    9_
$a Flubendazole, methyl ester of [5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamic acid, belongs to the group of benzimidazole anthelmintics, which are widely used in veterinary and human medicine. The phase I flubendazole biotransformation includes a hydrolysis of the carbamoyl methyl moiety accompanied by a decarboxylation (hydrolysed flubendazole) and a carbonyl reduction of flubendazole (reduced flubendazole). Flubendazole is a prochiral drug, hence a racemic mixture is formed during non-stereoselective reductions at the carbonyl group. Two bioanalytical HPLC methods were developed and validated for the determination of flubendazole and its metabolites in pig and pheasant hepatic microsomal and cytosolic fractions. Analytes were extracted from biomatrices into tert-butylmethyl ether. The first, achiral method employed a 250 mm x 4 mm column with octylsilyl silica gel (5 microm) and an isocratic mobile phase acetonitrile-0.025 M KH(2)PO(4) buffer pH 3 (28:72, v/v). Albendazole was used as an internal standard. The whole analysis lasted 27 min at a flow rate of 1 ml/min. The second, chiral HPLC method, was performed on a Chiralcel OD-R 250 mm x 4.6 mm column with a mobile phase acetonitrile-1 M NaClO(4) (4:6, v/v). This method enabled the separation of both reduced flubendazole enantiomers. The enantiomer excess was evaluated. The column effluent was monitored using a photodiode-array detector (scan or single wavelength at lambda=246 nm). Each of the analytes under study had characteristic UV spectrum, in addition, their chemical structures were confirmed by high-performance liquid chromatography-mass spectrometry (HPLC-MS) experiments. Stereospecificity in the enzymatic carbonyl reduction of flubendazole was observed. While synthetic racemic mixture of reduced flubendazole was separated to equimolar amounts of both enantiomers, practically only one enantiomer was detected in the extracts from all incubates.
650    _2
$a financování organizované $7 D005381
650    _2
$a zvířata $7 D000818
650    _2
$a anthelmintika $x analýza $7 D000871
650    _2
$a ptáci $7 D001717
650    _2
$a kalibrace $7 D002138
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a mebendazol $x analogy a deriváty $x analýza $7 D008463
650    _2
$a hmotnostní spektrometrie s elektrosprejovou ionizací $x metody $7 D021241
650    _2
$a spektrofotometrie ultrafialová $x metody $7 D013056
650    _2
$a stereoizomerie $7 D013237
650    _2
$a prasata $7 D013552
650    _2
$a tandemová hmotnostní spektrometrie $x metody $7 D053719
655    _2
$a validační studie $7 D023361
700    1_
$a Jira, Thomas
700    1_
$a Lísa, Miroslav $7 xx0090411
700    1_
$a Holčapek, Michal, $d 1971- $7 ola2002159192
700    1_
$a Szotáková, Barbora $7 jx20070426012
700    1_
$a Lamka, Jiří, $d 1953- $7 nlk19990073481
700    1_
$a Skálová, Lenka, $d 1965- $7 mzk2004230464
773    0_
$w MED00004968 $t Journal of chromatography. A, Including electrophoresis, mass spectrometry and other separation and detection methods $g Roč. 1149, č. 1 (2007), s. 112-120 $x 0021-9673
910    __
$a ABA008 $b x $y 8
990    __
$a 20090310084605 $b ABA008
991    __
$a 20100425180011 $b ABA008
999    __
$a ok $b bmc $g 707200 $s 569997
BAS    __
$a 3
BMC    __
$a 2007 $b 1149 $c 1 $d 112-120 $m Journal of chromatography. A, Including electrophoresis and other separation methods $x MED00004962 $n J Chromatogr A
LZP    __
$a 2010-b1/ipme

Najít záznam